Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by:
U.S. Army Medical Research and Materiel Command
ClinicalTrials.gov Identifier:
NCT00287469
First received: February 2, 2006
Last updated: October 25, 2016
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2004
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):